Food/Recall·FDA Recalls

a2 Platinum USA Label Infant Formula Recalled Because of Possible Health Risk

HighPublished May 2, 2026· AI-analyzed May 4, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

The a2 Milk Company has initiated a voluntary recall of three specific batches of its imported a2 Platinum Premium USA label infant formula (0-12 months) due to the presence of cereulide.

Who it affects

This recall affects The a2 Milk Company, US-based infant formula distributors, and retailers carrying the imported a2 Platinum Premium USA label product.

Why it matters

The presence of cereulide in infant formula is a significant safety concern as it is a heat-stable toxin, suggesting that standard thermal processing may not eliminate the risk once the toxin is present. For regulatory professionals, this underscores the importance of stringent raw material controls and environmental monitoring during production to prevent microbial metabolites from entering the final product.

Practical takeaway

Regulatory and quality teams should immediately verify if affected batch numbers are within their inventory, secure contaminated units from the supply chain, and review sterilization and testing protocols regarding heat-stable toxins like cereulide.

FDA source material

Boulder, CO – May 2, 2026 – The a2 Milk Company (“a2MC”) has voluntarily recalled three specific batches of its imported a2 Platinum Premium USA label infant formula 0-12 months (“Product”) due to the presence of cereulide. The Product is sold only in the United States. <br> Cereulide is a heat-stable t

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.